Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study.

[1]  M. Hoenigl,et al.  The current state of laboratory mycology and access to antifungal treatment in Europe: a European Confederation of Medical Mycology survey. , 2022, The Lancet. Microbe.

[2]  D. Seidel,et al.  COVID-19-associated fungal infections , 2022, Nature Microbiology.

[3]  J. Perfect,et al.  Invasive candidiasis: investigational drugs in the clinical development pipeline and mechanisms of action , 2022, Expert opinion on investigational drugs.

[4]  M. Hoenigl,et al.  Let's talk about sex characteristics—As a risk factor for invasive fungal diseases , 2022, Mycoses.

[5]  H. Tamim,et al.  The Utility of EQUAL Candida Score in Predicting Mortality in Patients with Candidemia , 2022, Journal of fungi.

[6]  A. Oliver,et al.  Fluconazole-resistant Candida parapsilosis clonally related genotypes: first report proving the presence of endemic isolates harbouring the Y132F ERG11 gene substitution in Spain. , 2022, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[7]  P. Ngamskulrungroj,et al.  EQUAL Candida score, an effective tool for predicting the outcomes of Candida tropicalis candidaemia: A retrospective cohort study , 2022, Mycoses.

[8]  M. Olsen,et al.  Attributable Mortality of Candida Bloodstream Infections in the Modern Era: A Propensity Score Analysis. , 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  J. Meis,et al.  The current state of clinical mycology in Africa: a European Confederation of Medical Mycology and International Society for Human and Animal Mycology survey. , 2022, The Lancet. Microbe.

[10]  M. Hoenigl,et al.  The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin , 2021, Drugs.

[11]  L. Pagano,et al.  EPICOVIDEHA: A Ready to Use Platform for Epidemiological Studies in Hematological Patients With COVID-19 , 2021, HemaSphere.

[12]  Á. Soriano,et al.  Early Stepdown From Echinocandin to Fluconazole Treatment in Candidemia: A Post Hoc Analysis of Three Cohort Studies , 2021, Open forum infectious diseases.

[13]  D. Marriott,et al.  Risk factors for candidaemia: A prospective multi‐centre case‐control study , 2020, Mycoses.

[14]  H. Seifert,et al.  Attributable mortality of candidemia after introduction of echinocandins , 2020, Mycoses.

[15]  B. Tarai,et al.  Multidrug-Resistant Candida auris Infections in Critically Ill Coronavirus Disease Patients, India, April–July 2020 , 2020, Emerging infectious diseases.

[16]  Dustin L. Stwalley,et al.  Effect of infectious disease consultation on mortality and treatment of patients with candida bloodstream infections: a retrospective, cohort study. , 2019, The Lancet. Infectious diseases.

[17]  J. Bohlius,et al.  Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis. , 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[18]  P. Hamal,et al.  ECMM CandiReg—A ready to use platform for outbreaks and epidemiological studies , 2019, Mycoses.

[19]  M. Antonelli,et al.  Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project , 2019, Critical Care.

[20]  D. Seidel,et al.  Global guidelines and initiatives from the European Confederation of Medical Mycology to improve patient care and research worldwide: New leadership is about working together , 2018, Mycoses.

[21]  B. Kullberg,et al.  Invasive Candidiasis. , 2019, The New England journal of medicine.

[22]  J. Meis,et al.  Candida Score : An ECMM score derived from current guidelines to measure QUAlity of Clinical Candidaemia Management , 2018 .

[23]  Felix Bongomin,et al.  Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision , 2017, Journal of fungi.

[24]  D. Seidel,et al.  FungiScope™—Global Emerging Fungal Infection Registry , 2017, Mycoses.

[25]  C. Steiner,et al.  Epidemiology of Hospitalizations Associated with Invasive Candidiasis, United States, 2002–2012 , 2017, Emerging infectious diseases.

[26]  J. Sobel,et al.  Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  P. Hamal,et al.  Invasive Candida infections in surgical patients in intensive care units: a prospective, multicentre survey initiated by the European Confederation of Medical Mycology (ECMM) (2006-2008). , 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[28]  J. Aguado,et al.  Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[29]  Nicolas Papon,et al.  Emerging and Emerged Pathogenic Candida Species: Beyond the Candida albicans Paradigm , 2013, PLoS pathogens.

[30]  T. Calandra,et al.  ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[31]  T. Calandra,et al.  ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[32]  D. Harrison,et al.  Risk factors for invasive fungal disease in critically ill adult patients: a systematic review , 2011, Critical care.

[33]  O. Faure,et al.  Epidemiology of Candidaemia in Europe: Results of 28-Month European Confederation of Medical Mycology (ECMM) Hospital-Based Surveillance Study , 2004, European Journal of Clinical Microbiology and Infectious Diseases.